Advanced Technologies & Treatments for Diabetes

📢We warmly invite researchers, clinicians, and healthcare professionals across Asia and beyond to submit their latest work. 📅Submission deadline: 1 July 2026 🔗Submit your abstract: attdasia.kenes.com/abstract-submi… #ATTDASIA26 #DiabetesCare #AbstractSubmission

Save the Date! ➡️ Join us live for a practical, evidence-based session on: "Initiating and Advancing #InsulinTherapy in #Type2Diabetes" 📅 25 March at 16:00 CET 👉 REGISTER NOW: bit.ly/4cH6tfi Supported by an educational grant from #Sanofi. #ATTDEducation #Diabetes

What a few days it’s been at #ATTD2026! 💚 So many conversations, ideas, and people coming together from all over the world to move diabetes technology forward. 📽️ Here are some of the final moments from this year’s conference. #DiabetesCare #DiabetesTechnology

📜Claim CME/CPD credits on the ATTD Education Portal. Complete the 5-minute evaluation to receive your certificate. 🎓Claim here: attd.kenes.com/cme-cpd-inform… #ATTD2026 #CME #ATTDEducation

As #ATTD2026 wraps up, it’s not really goodbye, it’s more like see you next time. 📍Paris 📆March 3-6, 2027 Another year to explore new science, share big ideas, and reconnect with this incredible community ⌛We’ll see you in Paris! #ATTD2027 #DiabetesInnovation

It’s hard to believe these few days are already behind us. 🙌As we officially close #ATTD2026, we celebrate not just the progress in diabetes technology and care, but the people behind it. Thank you for being part of it, Until next time!

Now @DrHArmstrong #GMFH2026 showing that purified fibers (beta-fructans) — or even high-fiber diets — may have negative effects in certain contexts (IBD, MS..), bc altered microbiomes ? Or purified fiber? Another thought-provoking talk challenging old concepts. @GMFHx

Exploring the next frontier of type 1 diabetes research at #ATTD2026! The plenary on Advancements in T1D: From Pathogenesis to Therapy highlights new insights into viral triggers of T1D, dendritic cell therapies, and biomarkers such as C-peptide for beta-cell function.

#ATTD2026 Live 📊 Parallel sessions exploring diabetes technology innovation, smart pens, AI in clinical practice, closed-loop systems, pediatric diabetes, obesity treatment, and new advances in glucose monitoring. The future of diabetes care continues to evolve.

Very powerful quote from parents of children who were screened for #T1D antibodies and the impact of a positive result before a full diagnosis requiring therapeutic treatments "people look at diabetes, at insulin, as palliative care" @ATTDconf #attd2026 #dedoc°

Great talk by @JensWalter15 at #GMFH2026 showing that fiber intake well beyond current recommendations (>35 g/day) could bring major health benefits. The real challenge? Adherence. The NiMe™ diet or fiber-fortified foods may help close the gap.@GMFHx

ESP: Investigación impactante utilizando un modelo de gemelo digital para optimizar los algoritmos de circuitos cerrados para mujeres con diabetes durante el ciclo menstrual X original de @DrLucyChambers

🤔Es útil el monitoreo continuo de glucosa #MCG en personas SIN diabetes para apoyar los cambios en el estilo de vida❓ La respuesta es: NO‼️ #ATTD2026 @ATTDconf

💡Session 1 at our #ATTD2026 Symposium: Dr. Hussain (@sugarydoc) presents the new "International consensus on the detection & monitoring of early-stage #T1D: a roadmap to European implementation", outlining policy recommendations to roll out T1D screening programmes in Europe.

NOT JUST A PATCH. Where fun style meets performance. Excellent❣️Ready for water, workouts, and beyond. The best part? Made BY➕FOR people with diabetes. 😉 #dedoc #voices #ATTD2026 #ATTDconf @dedocDE @ATTDconf @diabetes_chat @thediabeticsurv @vc_yukit @welshy_89 @Tims_Pants

Happening now at #ATTD2026 🔬 Parallel sessions and oral presentations exploring hypo- and hyperglycemia updates, cardiovascular risk in T1D, automated insulin delivery, closed-loop systems, new diabetes medications, and real-world CGM use.

A productive week for INNODIA at @ATTDconf Conference. Key moments: • General Assembly 2026 • Networking event • Strategic Supporters Breakfast Updates: Early T1D Detection, Data Lake, Agoralabs, Syno (with Syntactiq) and launch of myINNODIA.

Today at @ATTDconf Conference, INNODIA hosted its 2026 General Assembly and a Stakeholder Networking Event. Updates included: • Early T1D Detection program • INNODIA Data Lake • Collaboration with AgoraLabs • Work with Syntactiq on Syno • Launch of myINNODIA App #ATTD2026

🙌Our Regional Chair, Prof. @TBattelino opened our #ATTD2026 Symposium emphasising the urgent need to accelerate action to innovations in #diabetes care for all people living with diabetes. @ATTDconf